2025-10-21T11:28:07-07:00 2024-12-31 030528195 Beacon CPA PC 425 Madison Avenue 9th Floor New York NY 10017 990PF 2024-01-01 133912580 EMERALD FOUNDATION INC CO SOLOMON BLUM HEYMANN EMER 2122677600 40 WALL ST STE 1703 NEW YORK NY 10005 ANDREW W HEYMANN President 2025-10-21 true true Mark Ratafia CPA P00420791 2013078500 X 2024 2025-03-06 01:10:19Z X 29342456 X X 1104470 1104470 287188 10234437 287188 1391658 1391658 125000 125000 3750 3750 300000 150000 150000 38000 19000 19000 166096 83048 83048 15257 331 9926 113000 56500 56500 206628 189277 17351 967731 498156 464575 1547500 1547500 2515231 498156 2012075 -1123573 893502 183659 175372 175372 478363 657750 657750 13777596 12807316 12852741 10610704 10491088 14561223 1384420 1210122 1091764 3606 3606 26434742 25345254 29342456 0 X 26434742 25345254 26434742 25345254 26434742 25345254 26434742 -1123573 34085 25345254 25345254 Thru RBC #1684 P 2022-01-01 2024-12-31 73177 80051 -6874 -6874 Thru RBC #1684 P 2024-01-01 2024-12-31 1400000 1376945 23055 23055 Thru RBC #1684 P 2022-01-01 2024-12-31 2152554 2055770 96784 96784 Thru RBC #2248 P 2022-01-01 2024-12-31 149695 2937 146758 146758 Thru RBC #2248 P 2024-01-01 2024-12-31 1647000 1631059 15941 15941 Thru RBC #2248 P 2022-01-01 2024-12-31 4812011 4800487 11524 11524 287188 12420 12420 12420 13985 13985 1565 1565 false false false false false false false true true NY true false false false false true N/A SOLOMON BLUM HEYMANN LLP 2122677600 40 WALL STREET 35TH FLR NEW YORK NY 10005 false false false false false false false false false false false false false false false false true false false true false false false false JAMES P MAHAFFEY 40 WALL ST 35TH FLR NEW YORK NY 10005 Vice President 40.00 125000 3750 ANDREW W HEYMANN 40 WALL ST 35TH FLR NEW YORK NY 10005 Pres/director 8.00 0 LUCA CANTELLI 40 WALL ST35TH FLR NEW YORK NY 10005 Director 0.50 0 WILLIAM BLUM 40 WALL ST35TH FLR NEW YORK NY 10005 Treasurer 6.00 0 ERIKA KELLERHALS 9053 ESTATE THOMAS STE 101 VQ 00802 Director 0.50 0 NONE SOLOMON BLUM HEYMANN LLP 40 WALL ST 35TH FLR NEW YORK NY 10005 LEGAL, ACCOUNTING, ADMIN 466096 28323151 984064 0 29307215 0 29307215 439608 28867607 1443380 1443380 12420 12420 1430960 1430960 1430960 2012075 2012075 1430960 484999 15065 291231 162828 418508 1372631 2012075 0 1430960 581115 1953746 0 484999 1468747 15065 291231 162828 418508 581115 X CALIFORNIA INSITUTE OF TECHNOLOGY 1200 E CALIFORNIA BLVD PASADENA CA 91125 NONE PC To develop interpretable machine learning methods that link spatial phenotypes in imaging data of solid tumors with patient outcomes. 37500 JOHN HOPKINS UNIVERSITY 1800 ORLEANS ST BALTIMORE MD 21287 NONE PC To use tumor organoid and mouse models to determine how loss of claudin proteins impacts tumor invasion and metastasis. 37500 DANA-FARBER CANCER INSTITUTE 450 BROOKLINE AVE BOSTON MA 02215 NONE PC To map the transcriptional and protein changes induced by lactate and identify the mechanisms that cause NK suppression, on both NK and tumor cells, using high-throughput and unbiased approaches. 50000 UNIVERSITY OF MARYLAND SCH OF MEDIC 22 S GREENE ST BALTIMORE MD 21201 NONE PC TO INVESTIGATE THE REGULATION OF TREG LYMPHATIC TUMOR MIGRATION AND THE INTERACTION AMONG TREGS, LYMPHATIC ENDOTHELIAL CELLS, AND TUMORS TO DEVELOP STRATEGIES OF DELIVERING TARGETED THERAPIES LOCALLY INSTEAD OF SYSTEMICALLY. 75000 MASSACHUSETTS INSTITUTE OF TECHNOLO 500 MAIN ST CAMBRIDGE MA 02139 NONE PC To enhance nanoparticle accumulation in desired cell types to develop more effective and safer targeted nanotherapies. 75000 UNIVERSITY OF MARYLAND SCH OF MEDIC 22 S GREENE ST BALTIMORE MD 21201 NONE PC To investigate the regulation of Treg lymphatic tumor migration and the interaction among Tregs, lymphatic endothelial cells, and tumors to develop strategies of delivering targeted therapies locally instead of systemically. 75000 WEILL CORNELL MEDICINE 1300 YORK AVE NEW YORK NY 10065 NONE PC To characterize exosomes from nave and tumor-educated platelets and determine their contribution to metastatic dormancy and recurrence. 37500 FOX CHASE CANCER CENTER 333 COTTMAN AVE PHILADELPHIA PA 19111 NONE PC To investigate the role of Brg1-dependent epigenetic regulation on PDAC fibroblast pro-tumorigenic functions. 37500 WHITEHEAD INST FOR BIOMEDICAL RESEA 455 MAIN ST CAMBRIDGE MA 02142 NONE PC To uncover the set of cell-surface proteins that mediate essential interactions between PDAC cells and their microenvironment. 50000 JOHN HOPKINS UNIVERSITY 1800 ORLEANS ST BALTIMORE MD 21287 NONE PC To investigate how the colon microbiota and host genetics intersect to alter responsiveness to immunotherapy in colorectal cancer. 50000 SALK INSTITUTE FOR BIOLOGICAL STUDI 10010 N TORREY PINES RD LA JOLLA CA 92037 NONE PC TO USE INNOVATIVE CELL BIOLOGY TECHNIQUES COUPLED WITH GENOMICS TO INVESTIGATE THE ROLE OF MITOCHONDRIAL-DERIVED VESICLES IN CANCER CELL METABOLISM. 50000 UNIVERSITY OF KENTUCKY 741 S LIMESTONE BBSRB B363 LEXINGTON KY 40536 NONE PC TO UNDERSTAND HOW MALADAPTIVE CHANGES TO THE INTEGRATED STRESS RESPONSE PATHWAY ALTER THE FORCE GENERATING ABILITY OF HUMAN HEART CELLS AND DETERMINE IF PHARMACOLOGICAL MANIPULATION CAN RESCUE CARDIOMYOCYTE FUNCTION. 50000 CALIFORNIA INSITUTE OF TECHNOLOGY 1200 E CALIFORNIA BLVD PASADENA CA 91125 NONE PC To develop interpretable machine learning methods that link spatial phenotypes in imaging data of solid tumors with patient outcomes. 37500 SALK INSTITUTE FOR BIO STUDIES 10010 N TORREY PINES RD LA JOLLA CA 92037 NONE PC To use innovative cell biology techniques coupled with genomics to investigate the role of mitochondrial-derived vesicles in cancer cell metabolism. 50000 WHITEHEAD INST FOR BIOMEDICAL RESEA 455 MAIN ST CAMBRIDGE MA 02142 NONE PC To identify molecular mechanisms that help anaerobes cope with oxygen exposure and/or oxidative stress. 50000 WHITEHEAD INST FOR BIOMEDICAL RESEA 455 MAIN ST CAMBRIDGE MA 02142 NONE PC To identify molecular mechanisms that help anaerobes cope with oxygen exposure and/or oxidative stress. 50000 INSERM DR GRAND OUEST 63 QUAI MAGELLAN CS NANTES Cedex 1 FR 32116 NONE PC To determine the mechanism through which breast cancer cell clusters dissociate into single cells and proliferate at distant sites and to determine the impact of the new environment on metastasis formation. 50000 WHO WE PLAY FOR INC 106 DELEON ROAD COCOA BEACH FL 32931 NONE PC To screen young students for previously undiagnosed heart ailments and generate data that can be used to train AI programs to better evaluate electrocardiograms. 37500 NYU SCHOOL OF MEDICINE 550 First Avenue New York NY 10016 NONE PC To examine the cellular mechanisms through which dendrite-centric Alzheimer's disease pathologies result in cognitive dysfunction and hyper-excitability. 75000 HARVARD MEDICAL SCHOOL 25 Shattuck Street Boston MD 21287 NONE PC To study how SLC7A5 regulates metabolic reprogramming and signaling pathways that enable cancer cells to survive CDK4/6i treatment. 37500 UNIVERSITY OF PENNSYLVANIA 3400 Civic Center Boulevard Philadelphia PA 19104 NONE PC To understand the molecular mechanism underlying immunosuppression and immunoactivation and develop new treatment strategies for hepatic malignancies. 50000 WEILL CORNELL MEDICINE 1300 York Avenue New York NY 10065 NONE PC To identify regulators of lineage reversion that impact resistance to WNT-targeted therapies in colorectal cancer. 75000 CANCER RESEARCH UK CRUK 2 Redman Place London UK E20 1JQ NONE PC Sponsorship of CRUK conferences Sponsorship fee - Travel Bursaries for those attending the Black in Cancer Conference (2022). 10000 DANA-FARBER CANCER INSTITUTE 450 Brookline Avenue Boston MA 02215 NONE PC To map the transcriptional and protein changes induced by lactate and identify the mechanisms that cause NK suppression, on both NK and tumor cells, using high-throughput and unbiased approaches. 50000 HARVARD MEDICAL SCHOOL 25 Shattuck Street Boston MA 02115 NONE PC To study how SLC7A5 regulates metabolic reprogramming and signaling pathways that enable cancer cells to survive CDK4/6i treatment. 37500 MASSACHUSETTS INSTITUTE OF TECHNOLO 500 Main Street Cambridge MA 02139 NONE PC To study how ferroptosis-based strategies can enhance the efficacy of immunotherapies in breast cancer. 87500 NYU SCHOOL OF MEDICINE 550 First Avenue New York NY 10016 NONE PC To characterize interactions between proteins that associate only with the KRAS4A isoform to identifying pathways that can be rationally targeted to achieve a more comprehensive interruption of KRAS stimulation. 37500 UNIVERSITY OF PENNSYLVANIA 3400 Civic Center Boulevard Philadelphia PA 19104 NONE PC To understand the molecular mechanism underlying immunosuppression and immunoactivation and develop new treatment strategies for hepatic malignancies. 50000 UNIVERSITY OF KENTUCKY 741 S Limestone BBSRB B363 Lexington KY 40536 NONE PC To understand how maladaptive changes to the integrated stress response pathway alter the force generating ability of human heart cells and determine if pharmacological manipulation can rescue cardiomyocyte function. 50000 UNIVERSITY OF MICHIGAN 3260 Biological Sciences Building Ann Arbor MI 48109 NONE PC To use tumor organoid and mouse models to determine how loss of Claudin proteins impacts tumor invasion and metastasis. 50000 WEILL CORNELL MEDICINE 1300 York Avenue New York NY 10065 NONE PC To characterize exosomes from nave and tumor-educated platelets and determine their contribution to metastatic dormancy and recurrence. 37500 1547500 14 1104470 18 287188 1391658 1391658 false false false false false false false false false false accounting fees 38000 19000 0 19000 Certs of Deposit & Other Fixed Inc Secs 1210122 1091764 Telus Corp 20170 13560 BGC Group Inc 22590 543600 Forian Inc 73788 12358 BP 198928 192140 Shopify Inc 53634 53165 Vodafone Group PLC 1646080 424500 Abbott Laboratories 109496 141388 Abbvie Inc 83857 177700 Alphabet Inc Class A & Class C 134610 854700 Altria Group Inc 186638 313740 Amazon.com Inc 44035 658170 Apple Inc 86071 1752940 Berkshire Hathaway Inc Del CL B 215378 679920 Berkshire Hathaway Inc Del CL A 146401 1361840 Block Inc 15115 21248 Chevron Corporation 106211 144840 Costco Wholesale corp 218268 687203 CVS Health Corporation 30079 22445 Eli Lilly & Co 71530 386000 Exxon Mobil Corp 16760 53785 Ford Motor Co 116407 99000 Intel Corp 75876 30075 Kraft Heinz Company 789007 460650 Microsoft Corp 25936 526875 Paypal Holdings Inc 42329 42675 Select Sector Spdr Trust 72126 85660 Waste Management Inc 43487 403580 Cleveland Cliffs Inc 69391 94000 ETF Managers Trust 142183 186225 Lumen Technologies Inc 1745411 541620 Mankind Corporation 19721 32150 Citigroup Inc 77069 105585 Ecolab Inc 43475 58580 Global X Funds 73970 93730 Liberty Broadband Corporation 59900 37380 Paramount Global 165073 52300 Warner Bros Discovery Inc 41408 26425 IAC Inc 121821 64710 SLR Investment Corp 2622632 2217346 Sterling Infrastructure 11005 84225 SPDR Gold TR 418644 605325 Annaly Capital Management 36756 27450 Invesco Exchange Traded FD TR 49016 49960 Pfizer Inc 41562 39795 Albemarle Corporation 49195 43040 Kenvue Inc 43189 42700 Organon & Co 14860 14920 Corporate Stocks Sold in 2024 12807316 12852741 Legal Fees 300000 150000 0 150000 Dividends Receivable 3606 3606 advisory fees 186531 186531 Computer supplies 301 301 Filing Fees 750 750 Insurance Expense 10984 2746 8238 misc 7582 7582 Office Expense 480 480 Return of Capital 34085 Other professional fees 166096 83048 0 83048 EXCISE TAX 5000 FOREIGN TAXES AND FEES 331 331 PAYROLL TAXES 9926 9926